Pregnancy and breastfeeding require a cautious approach to medicines, supplements and herbal products. Cannabis-derived products—including CBD-labelled and Vijaya-containing formulations—should not be assumed safe because they are described as natural, Ayurvedic or non-intoxicating.
Major health authorities discourage cannabis use during pregnancy and breastfeeding, and the available evidence does not establish over-the-counter CBD products as safe in these settings.
CBD is not automatically safe because it is not THC
CBD and THC are different compounds, but that does not make CBD risk-free. Concerns include:
- Limited pregnancy-specific safety data.
- Potential effects on fetal or infant development.
- Medicine interactions.
- Liver-related effects.
- Drowsiness and impaired caregiving.
- Product contamination or inaccurate labelling.
- Presence of other cannabinoids in full-spectrum products.
A label saying “THC-free” should also be evaluated against a relevant test and detection limit.
Pregnancy
The U.S. Food and Drug Administration advises against using CBD, THC and cannabis in any form during pregnancy. Published evidence on cannabis exposure raises concerns including fetal growth restriction, low birth weight, preterm birth and possible effects on brain development, although risks can vary and observational research has limitations.
The absence of definitive data for a particular oil or gummy is not evidence of safety.
Breastfeeding
Cannabis constituents can pass into breast milk, and the duration and clinical significance depend on the compound, pattern of use and other factors. Evidence is insufficient to define a safe exposure threshold for CBD or cannabis products during breastfeeding.
Potential caregiver impairment also matters. Drowsiness, dizziness or altered alertness can affect safe feeding, carrying and supervision.
Trying to conceive and fertility
People planning pregnancy should discuss cannabinoid and herbal-product use with a clinician before conception. A practitioner may need to consider:
- Frequency and duration of use.
- Exact formulation.
- Other medicines.
- Underlying health conditions.
- Fertility treatment.
- Exposure by either partner.
Do not wait for a positive pregnancy test if use is regular or medically supervised.
Prescription products
If a cannabinoid-containing medicine was prescribed for a serious condition, do not stop it suddenly without speaking to the prescriber. Abruptly stopping treatment can create risks of its own.
The clinician should compare:
- Expected benefit.
- Known and uncertain fetal or infant risks.
- Risks of untreated illness.
- Alternative treatments.
- Dose and monitoring.
This is an individual medical decision, not a general product-page recommendation.
Accidental exposure
If exposure occurred before pregnancy was known:
- Do not panic.
- Record the product, strength, amount and dates.
- Keep the packaging or photograph the label.
- Tell the obstetric clinician.
- Do not continue or restart without advice.
Seek urgent care for severe symptoms such as loss of consciousness, breathing difficulty, seizure, persistent vomiting or significant bleeding.
Product-quality concerns
Unregulated or poorly documented products can add uncertainty through:
- Incorrect CBD or THC content.
- Undeclared ingredients.
- Pesticides or heavy metals.
- Residual solvents.
- Microbial contamination.
- Confusing serving directions.
A general “lab tested” statement does not answer whether a finished batch was tested for all relevant risks.
Questions for the clinician
- Is there a safer alternative for the reason I am using this?
- Should I stop now, taper or continue temporarily?
- Could it interact with my medicines?
- Is additional monitoring needed?
- What should I do about accidental exposure?
- When can use be reconsidered after pregnancy or breastfeeding?
Guidance for Sanan Organix customers
Disclose pregnancy, planned pregnancy and breastfeeding before any consultation involving a cannabinoid- or Vijaya-containing formulation. Do not use a product simply because another person received it.
Start a confidential consultation
References
- U.S. FDA, What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding: https://www.fda.gov/consumers/consumer-updates/what-you-should-know-about-using-cannabis-including-cbd-when-pregnant-or-breastfeeding
- U.S. FDA, regulation and consumer information for cannabis-derived products: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
- World Health Organization, cannabidiol critical review: https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabidiol
Disclaimer
This article is general education and does not replace obstetric, paediatric or prescribing advice. Do not start, continue, stop or change prescribed treatment without consulting an appropriately qualified clinician.
